Progression of non-small-cell lung cancer during the interval before stereotactic body radiotherapy

International Journal of Radiation Oncology Biology Physics

Volumn 82, Issue 1, 2012, Pages 463-467

  Murai, Taro ^a   Shibamoto, Yuta ^a   Baba, Fumiya ^a   Hashizume, Chisa ^b   Mori, Yoshimasa ^b   Ayakawa, Shiho ^c   Kawai, Tatsuya ^a   Takemoto, Shinya ^a   Sugie, Chikao ^a   Ogino, Hiroyuki ^a  

^a NAGOYA CITY UNIVERSITY GRADUATE SCHOOL OF MEDICAL SCIENCES   (Japan)

^b NAGOYA KYORITSU HOSPITAL   (Japan)

^c NAGOYA DAINI RED CROSS HOSPITAL   (Japan)

Author keywords

Non small cell lung cancer; Stereotactic body radiotherapy; Waiting time

Indexed keywords

COMPUTED TOMOGRAPHY; DISEASE PROGRESSION; NON SMALL CELL LUNG CANCER; RATE OF INCREASE; SQUAMOUS CELL CARCINOMA; STEREOTACTIC BODY RADIOTHERAPY; TNM STAGE; TREATMENT PLANNING; TUMOR SIZE; TUMOR VOLUMES; WAITING-TIME;

BIOLOGICAL ORGANS; CELLS; COMPUTERIZED TOMOGRAPHY; DISEASES; RADIOTHERAPY; TOMOGRAPHY;

TUMORS;

ADULT; AGED; ARTICLE; CANCER GROWTH; CANCER SIZE; CANCER STAGING; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; HOSPITAL ADMISSION; HUMAN; LUNG ADENOCARCINOMA; LUNG NON SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; SQUAMOUS CELL CARCINOMA; STEREOTACTIC BODY RADIATION THERAPY; TIME; TREATMENT PLANNING; TUMOR VOLUME; WAITING TIME;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; CARCINOMA, SQUAMOUS CELL; DISEASE PROGRESSION; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; PATIENT POSITIONING; RADIOSURGERY; RADIOTHERAPY PLANNING, COMPUTER-ASSISTED; STATISTICS, NONPARAMETRIC; TIME FACTORS; TUMOR BURDEN;

EID: 83955162979     PISSN: 03603016     EISSN: 1879355X     Source Type: Journal    
DOI: 10.1016/j.ijrobp.2010.10.001     Document Type: Article

References (22)

1. M. Uematsu, A. Shioda, and A. Suda Computed tomography-guided frameless stereotactic radiotherapy for stage I non-small-cell lung cancer: A 5-year experience Int J Radiat Oncol Biol Phys 51 2001 666 670
2. H. Onishi, H. Shirato, and Y. Nagata Hypofractionated stereotactic radiotherapy (HypoFXSRT) for stage I non-small cell lung cancer: Updated results of 257 patients in a Japanese multi-institutional study J Thorac Oncol 2 Suppl 3 2007 S94 S100
3. J.Y. Chang, P.A. Balter, and L. Dong Stereotactic body radiation therapy in centrally and superiorly located stage I or isolated recurrent non-small-cell lung cancer Int J Radiat Oncol Biol Phys 72 2008 967 971
4. J.D. Bradley, I. El Naqa, and R.E. Drzymala Stereotactic body radiation therapy for early-stage non-small-cell lung cancer: The pattern of failure is distant Int J Radiat Oncol Biol Phys 77 2010 1146 1150
5. A.J. Fakiris, R.C. McGarry, and C.T. Yiannoutsos Stereotactic body radiation therapy for early-stage non-small-cell lung carcinoma: Four-year results of a prospective phase II study Int J Radiat Oncol Biol Phys 75 2009 677 682
6. Z. Chen, W. King, and R. Pearcey The relationship between waiting time for radiotherapy and clinical outcomes: A systematic review of the literature Radiother Oncol 87 2008 3 16
7. A. Fortin, I. Bairati, and M. Albert Effect of treatment delay on outcome of patients with early stage head-and-neck carcinoma receiving radical radiotherapy Int J Radiat Oncol Biol Phys 52 2002 929 936
8. British Thoracic Society BTS recommendations to respiratory physicians for organising the care of patients with lung cancer. The Lung Cancer Working Party of the British Thoracic Society Standards of Care Committee Thorax 53 Suppl 1 1998 S1 S8
9. F. Baba, Y. Shibamoto, and N. Tomita Stereotactic body radiotherapy for stage I lung cancer and small lung metastasis: Evaluation of an immobilization system for suppression of respiratory tumor movement and preliminary results Radiat Oncol 4 2009 15
10. T. Aoki, H. Nakata, and H. Watanabe Evolution of peripheral lung adenocarcinomas: CT findings correlated with histology and tumor doubling time Am J Roentgenol 174 2000 763 768
11. M. Hasegawa, S. Sone, and S. Takashima Growth rate of small lung cancers detected on mass CT screening Br J Radiol 73 2000 1252 1259
12. S.G. Jennings, H.T. Winer-Muram, and M. Tann Distribution of stage I lung cancer growth rates determined with serial volumetric CT measurements Radiology 241 2006 554 563
13. H.T. Winer-Muram, S.G. Jennings, and R.D. Tarver Volumetric growth rate of stage I lung cancer prior to treatment: Serial CT scanning Radiology 223 2002 798 805
14. Y. Shibamoto, T. Shibata, and S. Miyatake Assessment of the proliferative activity and radiosensitivity of human tumours using the cytokinesis-block micronucleus assay Br J Cancer 70 1994 67 71
15. Y. Shibamoto, O. Ike, and H. Mizuno Proliferative activity and micronucleus frequency after radiation of lung cancer cells as assessed by the cytokinesis-block method and their relationship to clinical outcome Clin Cancer Res 4 1998 677 682
16. H.D. Thames Jr., L.J. Peters, and H.R. Withers Accelerated fractionation versus hyperfractionation: rationales for several treatments per day Int J Radiat Oncol Biol Phys 9 1983 127 138
17. K.R. Trott, and J. Kummermehr What is known about tumour proliferation rates to choose between accelerated fractionation or hyperfractionation? Radiother Oncol 3 1985 1 9
18. D.J. Raz, J.A. Zell, and I. Ou Natural history of stage I non-small cell lung cancer Chest 132 2007 193 199
19. A. Motohiro, H. Ueda, and H. Komatsu Prognosis of non-surgically treated, clinical stage I lung cancer patients in Japan Lung Cancer 36 2002 65 69
20. J.K. Olsson, E.M. Schultz, and M.K. Gould Timeliness of care in patients with lung cancer: A systematic review Thorax 64 2009 749 756
21. N. O'Rourke, and R. Edwards Lung cancer treatment waiting times and tumour growth Clin Oncol (R Coll Radiol) 12 2000 141 144
22. A.R. Jensen, J. Mainz, and J. Overgaard Impact of delay on diagnosis and treatment of primary lung cancer Acta Oncol 41 2002 147 152